Tocilizumab Injection

Generic name: Pronounced as (toe'' si liz' oo mab)
Brand names
  • Actemra®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2021

Tocilizumab injection is currently being studied for the treatment of coronavirus disease 2019 (COVID-19) in combination with corticosteroids in people who require supplemental oxygen, a ventilator, or who need extracorporeal membrane oxygenation (ECMO; a device that adds oxygen to the blood). The FDA has approved an Emergency Use Authorization (EUA) to allow distribution of tocilizumab injection to treat certain adults and children 2 years of age and older who are hospitalized with a COVID-19 infection.

Using tocilizumab injection may decrease your ability to fight infection from bacteria, viruses, and fungi and increase the risk that you will get a serious or life-threatening infection that may spread through the body. Tell your doctor if you often get any type of infection or if you have or think you may have any type of infection now. This includes minor infections (such as open cuts or sores), infections that come and go (such as cold sores), and ongoing infections that do not go away. Also tell your doctor if you have or have ever had diabetes, human immunodeficiency virus (HIV), or any condition that affects your immune system, and if you live, have ever lived, or traveled to areas such as the Ohio and Mississippi River valleys and the Southwest where severe fungal infections are more common. Ask your doctor if you do not know if these infections are common in your area. Also tell your doctor if you are taking: abatacept (Orencia); adalimumab (Humira); anakinra (Kineret); certolizumab (Cimzia); etanercept (Enbrel); golimumab (Simponi); infliximab (Remicade); medications that suppress the immune system such as azathioprine (Azasan, Imuran), cyclosporine (Gengraf, Neoral, Sandimmune), methotrexate (Otrexup, Trexall, others), sirolimus (Rapamune), and tacrolimus (Prograf); oral steroids such as dexamethasone, methylprednisolone, and prednisone (Rayos); or rituximab (Rituxan). If you experience any of the following symptoms, call your doctor immediately: fever; chills; sweating; difficulty breathing; sore throat; cough; weight loss; diarrhea; stomach pain; blood in phlegm; extreme tiredness; muscle aches; warm, red, or painful skin; sores on the skin or in the mouth; burning when you urinate; frequent urination; or other signs of infection.

You may be infected with tuberculosis (TB; a type of lung infection) or hepatitis B (a type of liver disease) but not have any symptoms of the disease. In this case, tocilizumab injection may increase the risk that your infection will become more serious and you will develop symptoms. Your doctor will perform a skin test to see if you have an inactive TB infection and may order blood tests to see if you have an inactive hepatitis B infection. If necessary, your doctor will give you medication to treat this infection before you start using tocilizumab injection. Tell your doctor if you have or have ever had TB or hepatitis B, if you have visited any country where TB is common, or if you have been around someone who has TB. If you have any of the following symptoms of TB, or if you develop any of these symptoms during your treatment, call your doctor immediately: cough, chest pain, coughing up blood or mucus, weakness or tiredness, weight loss, loss of appetite, chills, fever, or night sweats. Also call your doctor immediately if you have any of these symptoms of hepatitis B or if you develop any of these symptoms during or after your treatment: excessive tiredness, yellowing of the skin or eyes, loss of appetite, nausea, vomiting, muscle aches, dark urine, clay-colored bowel movements, fever, chills, stomach pain, or rash.

Keep all appointments with your doctor and the laboratory. Your doctor will monitor your health carefully to be sure you do not develop a serious infection. Your doctor will order certain lab tests before and during your treatment to check your body's response to tocilizumab injection.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with tocilizumab injection and each time you receive the medication. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of using tocilizumab injection.

Tocilizumab injection is used alone or in combination with other medications to relieve the symptoms of certain types of arthritis and other conditions including:

  • rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in adults who have not been helped by other disease-modifying antirheumatic drugs (DMARDs),

  • giant cell arteritis (a condition that causes swelling of blood vessels, especially in the scalp and head) in adults,

  • systemic sclerosis-associated interstitial lung disease (SSc-ILD; also known as scleroderma-associated ILD: a lung disease that involves scarring of the lungs) in adults,

  • polyarticular juvenile idiopathic arthritis (PJIA; a type of childhood arthritis that affects five or more joints during the first six months of the condition, causing pain, swelling, and loss of function) in children 2 years of age or older.

  • systemic juvenile idiopathic arthritis (SJIA; a condition in children that causes inflammation in different areas of the body, causing fever, joint pain and swelling, loss of function, and delays in growth and development) in children 2 years of age or older,

  • cytokine release syndrome (a severe and possibly life-threatening reaction) in adults and children 2 years of age or older after receiving certain immunotherapy infusions.

Tocilizumab injection is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of interleukin-6, a substance in the body that causes inflammation.

Tocilizumab injection comes as a solution (liquid) to be injected intravenously (into a vein) about over 1 hour by a doctor or nurse in a medical office or hospital outpatient clinic or as a prefilled syringe to inject subcutaneously (just under the skin) by yourself at home.

When tocilizumab is given to treat rheumatoid arthritis, it is usually given intravenously once every 4 weeks or subcutaneously once every week or every other week.

When tocilizumab is given to treat giant cell arteritis, it is usually given subcutaneously once every week or every other week.

When tocilizumab is given to treat systemic sclerosis-associated interstitial lung disease, it is usually given subcutaneously once weekly.

When tocilizumab is given to treat polyarticular juvenile idiopathic arthritis, it is usually given intravenously once every 4 weeks or subcutaneously once every 2 or 3 weeks.

When tocilizumab is given to treat systemic juvenile idiopathic arthritis, it is usually given intravenously once every 2 weeks or subcutaneously once every week or once every 2 weeks.

When tocilizumab is given intravenously to treat cytokine release syndrome, it is usually given as one dose, but up to 3 additional doses may be given at least 8 hours apart.

You will receive your first subcutaneous dose of tocilizumab injection in your doctor's office. If you will be injecting tocilizumab injection subcutaneously by yourself at home or having a friend or relative inject the medication for you, your doctor will show you or the person who will be injecting the medication how to inject it. You and the person who will be injecting the medication should also read the written instructions for use that come with the medication.

Thirty minutes before you are ready to inject tocilizumab injection, you will need to remove the medication from the refrigerator, take it out of its carton, and allow it to reach room temperature. When removing a prefilled syringe from the box, be careful not to touch the trigger fingers on the syringe. Do not try to warm the medication by heating it in a microwave, placing it in warm water, or through any other method.

Do not remove the cap from the prefilled syringe while the medication is warming. You should remove the cap no more than 5 minutes before you inject the medication. Do not replace the cap after you remove it. Do not use the syringe if you drop it on the floor.

Check the prefilled syringe to be sure that the expiration date printed on the package has not passed, Holding the syringe with the covered needle pointing down, look closely at the liquid in the syringe. The liquid should be clear or pale yellow and should not be cloudy or discolored or contain lumps or particles. Call your pharmacist if there are any problems with the package or the syringe and do not inject the medication.

You may inject tocilizumab injection on the front of the thighs or anywhere on your stomach except your navel (belly button) and the area 2 inches around it. If another person is injecting your medication, the outer area of the upper arms also may be used. Do not inject the medication into skin that is tender, bruised, red, hard, or not intact, or that has scars, moles, or bruises. Choose a different spot each time you inject the medication, at least 1 inch away from a spot that you have used before. If the full dose is not injected, call your doctor or pharmacist.

Do not reuse tocilizumab prefilled syringes and do not recap the syringes after use. Discard any used syringes in a puncture-resistant container and ask your pharmacist how to throw away the container.

Tocilizumab injection may help control your symptoms, but it will not cure your condition. Your doctor will watch you carefully to see how well tocilizumab injection works for you. Your doctor may adjust your dose or delay your treatment if you have certain changes in your laboratory results. It is important to tell your doctor how you are feeling during your treatment.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving tocilizumab injection,

  • tell your doctor and pharmacist if you are allergic to tocilizumab, any other medications, or any of the ingredients in tocilizumab injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin, others) and naproxen (Aleve, Naprosyn, others); cholesterol-lowering medications (statins) such as atorvastatin (Lipitor, in Caduet), lovastatin (Altoprev, in Advicor), and simvastatin (Zocor, in Vytorin); oral contraceptives (birth control pills); or theophylline (Elixophyllin, Theo-24, others). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with tocilizumab injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have or have ever had cancer; diverticulitis (small pouches in the lining of the large intestine that can become inflamed); ulcers in your stomach or intestines; high cholesterol and triglycerides; any condition that affects the nervous system such as multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control) or chronic inflammatory demyelinating polyneuropathy (CIDP; a disorder of the immune and nervous systems); or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while receiving tocilizumab injection, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving tocilizumab injection.

  • ask your doctor whether you should receive any vaccinations before you begin your treatment with tocilizumab injection. If possible, all vaccinations for children should be brought up to date before beginning treatment. Do not have any vaccinations during your treatment without talking to your doctor.

Unless your doctor tells you otherwise, continue your normal diet.

If you miss an appointment to receive a tocilizumab infusion, call your doctor.

If you forget to inject a subcutaneous dose of tocilizumab, inject the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not inject a double dose to make up for a missed one. Call your doctor or pharmacist if you do not know when to inject tocilizumab injection.

  • Tocilizumab injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • runny nose or sneezing

    • redness, itching, pain, or swelling in the place where tocilizumab was injected

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

    • rash

    • flushing

    • hives

    • itching

    • swelling of the eyes, face, lips, tongue, throat, arms, hands, feet, ankles, or lower legs

    • difficulty breathing or swallowing

    • chest pain

    • dizziness or fainting

    • fever, ongoing stomach-area pain, or change in bowel habits

    • yellow eyes or skin; right upper abdominal pain; unexplained bruising or bleeding; loss of appetite; confusion; yellow or brown-colored urine; or pale stools

  • Tocilizumab may increase the risk of developing certain types of cancer. Talk to your doctor about the risks of receiving this medication.

  • Tocilizumab injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the package it came in, away from light, tightly closed, and out of reach of children. Store tocilizumab injection in the refrigerator, but do not freeze it. Keep the prefilled syringes dry. Discard any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Ask your pharmacist any questions you have about tocilizumab injection.

Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The metabolism of Repaglinide can be increased when combined with Tocilizumab.
Montelukast Montelukast The metabolism of Montelukast can be increased when combined with Tocilizumab.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Tocilizumab is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Delavirdine can be increased when combined with Tocilizumab.
Nevirapine Nevirapine The metabolism of Nevirapine can be increased when combined with Tocilizumab.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be increased when combined with Tocilizumab.
Dolasetron Dolasetron The metabolism of Dolasetron can be increased when combined with Tocilizumab.
Aminophylline Aminophylline The metabolism of Aminophylline can be increased when combined with Tocilizumab.
Anagrelide Anagrelide The metabolism of Anagrelide can be increased when combined with Tocilizumab.
Candesartan Candesartan The metabolism of Candesartan can be increased when combined with Tocilizumab.
Cilostazol Cilostazol The metabolism of Cilostazol can be increased when combined with Tocilizumab.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be increased when combined with Tocilizumab.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Erythromycin can be increased when combined with Tocilizumab.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be increased when combined with Tocilizumab.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be increased when combined with Tocilizumab.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Tocilizumab.
Paregoric Paregoric The metabolism of Morphine can be increased when combined with Tocilizumab.
Penbutolol Penbutolol The metabolism of Acebutolol can be increased when combined with Tocilizumab.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Tocilizumab.
Ranitidine Ranitidine The metabolism of Ranitidine can be increased when combined with Tocilizumab.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Tocilizumab.
Tizanidine Tizanidine The metabolism of Tizanidine can be increased when combined with Tocilizumab.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Tocilizumab.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be increased when combined with Tocilizumab.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be increased when combined with Tocilizumab.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Tocilizumab.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tocilizumab.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Tocilizumab.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Tocilizumab.
Metoclopramide Injection Metoclopramide Injection The metabolism of Metoclopramide can be increased when combined with Tocilizumab.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be increased when combined with Tocilizumab.
Morphine Injection Morphine Injection The metabolism of Morphine can be increased when combined with Tocilizumab.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be increased when combined with Tocilizumab.
Altretamine Altretamine The metabolism of Amphetamine can be increased when combined with Tocilizumab.
Cyclosporine Cyclosporine Tocilizumab may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be increased when combined with Tocilizumab.
Torsemide Torsemide The metabolism of Torasemide can be increased when combined with Tocilizumab.
Olanzapine Olanzapine The metabolism of Olanzapine can be increased when combined with Tocilizumab.
Alosetron Alosetron The metabolism of Alosetron can be increased when combined with Tocilizumab.
Dofetilide Dofetilide The metabolism of Dofetilide can be increased when combined with Tocilizumab.
Hydroxychloroquine Hydroxychloroquine The metabolism of Tocilizumab can be increased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be increased when combined with Tocilizumab.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be increased when combined with Tocilizumab.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Tocilizumab.
Zaleplon Zaleplon The metabolism of Zaleplon can be increased when combined with Tocilizumab.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Tocilizumab.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Tocilizumab.
Trimipramine Trimipramine The metabolism of Trimipramine can be increased when combined with Tocilizumab.
Etanercept Injection Etanercept Injection Tocilizumab may increase the immunosuppressive activities of Etanercept.
Tenofovir Tenofovir The metabolism of Tenofovir can be increased when combined with Tocilizumab.
Sirolimus Sirolimus The metabolism of Sirolimus can be increased when combined with Tocilizumab.
Dutasteride Dutasteride The metabolism of Dutasteride can be increased when combined with Tocilizumab.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Tocilizumab.
Eplerenone Eplerenone The metabolism of Eplerenone can be increased when combined with Tocilizumab.
Escitalopram Escitalopram The metabolism of Escitalopram can be increased when combined with Tocilizumab.
Zonisamide Zonisamide The metabolism of Zonisamide can be increased when combined with Tocilizumab.
Adalimumab Injection Adalimumab Injection Tocilizumab may increase the immunosuppressive activities of Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Tocilizumab.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be increased when combined with Tocilizumab.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Glatiramer is combined with Tocilizumab.
Atazanavir Atazanavir The metabolism of Atazanavir can be increased when combined with Tocilizumab.
Almotriptan Almotriptan The metabolism of Almotriptan can be increased when combined with Tocilizumab.
Eletriptan Eletriptan The metabolism of Eletriptan can be increased when combined with Tocilizumab.
Omalizumab Injection Omalizumab Injection The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be increased when combined with Tocilizumab.
Vardenafil Vardenafil The metabolism of Vardenafil can be increased when combined with Tocilizumab.
Aprepitant Aprepitant The metabolism of Aprepitant can be increased when combined with Tocilizumab.
Tegaserod Tegaserod The metabolism of Tegaserod can be increased when combined with Tocilizumab.
Tadalafil Tadalafil The metabolism of Tadalafil can be increased when combined with Tocilizumab.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be increased when combined with Tocilizumab.
Progesterone Progesterone The metabolism of Progesterone can be increased when combined with Tocilizumab.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Tocilizumab.
Infliximab Injection Infliximab Injection Tocilizumab may increase the immunosuppressive activities of Infliximab.
Protriptyline Protriptyline The metabolism of Protriptyline can be increased when combined with Tocilizumab.
Duloxetine Duloxetine The metabolism of Duloxetine can be increased when combined with Tocilizumab.
Norethindrone Norethindrone The metabolism of Norethisterone can be increased when combined with Tocilizumab.
Bosentan Bosentan The metabolism of Bosentan can be increased when combined with Tocilizumab.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be increased when combined with Tocilizumab.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Natalizumab.
Erlotinib Erlotinib The serum concentration of Erlotinib can be decreased when it is combined with Tocilizumab.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be decreased when it is combined with Tocilizumab.
Solifenacin Solifenacin The metabolism of Solifenacin can be increased when combined with Tocilizumab.
Voriconazole Voriconazole The metabolism of Voriconazole can be increased when combined with Tocilizumab.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be increased when combined with Tocilizumab.
Entecavir Entecavir The metabolism of Entecavir can be increased when combined with Tocilizumab.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tocilizumab.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tocilizumab.
Ramelteon Ramelteon The metabolism of Ramelteon can be increased when combined with Tocilizumab.
Darifenacin Darifenacin The metabolism of Darifenacin can be increased when combined with Tocilizumab.
Fentanyl Fentanyl The metabolism of Fentanyl can be increased when combined with Tocilizumab.
Tipranavir Tipranavir The metabolism of Tipranavir can be increased when combined with Tocilizumab.
Felbamate Felbamate The metabolism of Felbamate can be increased when combined with Tocilizumab.
Ranolazine Ranolazine The metabolism of Ranolazine can be increased when combined with Tocilizumab.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Abatacept is combined with Tocilizumab.
Rasagiline Rasagiline The metabolism of Rasagiline can be increased when combined with Tocilizumab.
Imatinib Imatinib The metabolism of Imatinib can be increased when combined with Tocilizumab.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be increased when combined with Tocilizumab.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Tocilizumab.
Gefitinib Gefitinib The metabolism of Gefitinib can be increased when combined with Tocilizumab.
Paliperidone Paliperidone The metabolism of Paliperidone can be increased when combined with Tocilizumab.
Bortezomib Bortezomib The metabolism of Bortezomib can be increased when combined with Tocilizumab.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Tocilizumab.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tocilizumab.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Tocilizumab.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Tocilizumab.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Tocilizumab.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Tocilizumab.
Primaquine Primaquine The metabolism of Primaquine can be increased when combined with Tocilizumab.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Tocilizumab.
Cetuximab Injection Cetuximab Injection The risk or severity of adverse effects can be increased when Cetuximab is combined with Tocilizumab.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be increased when combined with Tocilizumab.
Ranibizumab Injection Ranibizumab Injection The risk or severity of adverse effects can be increased when Ranibizumab is combined with Tocilizumab.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be increased when combined with Tocilizumab.
Retapamulin Retapamulin The metabolism of Retapamulin can be increased when combined with Tocilizumab.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Vorinostat is combined with Tocilizumab.
Sorafenib Sorafenib The metabolism of Sorafenib can be increased when combined with Tocilizumab.
Sunitinib Sunitinib The metabolism of Sunitinib can be increased when combined with Tocilizumab.
Dronabinol Dronabinol The metabolism of Dronabinol can be increased when combined with Tocilizumab.
Lapatinib Lapatinib The metabolism of Lapatinib can be increased when combined with Tocilizumab.
Dasatinib Dasatinib The metabolism of Dasatinib can be increased when combined with Tocilizumab.
Mexiletine Mexiletine The metabolism of Mexiletine can be increased when combined with Tocilizumab.
Panitumumab Injection Panitumumab Injection The risk or severity of adverse effects can be increased when Panitumumab is combined with Tocilizumab.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Tocilizumab.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be increased when combined with Tocilizumab.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Nelarabine is combined with Tocilizumab.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Tocilizumab.
Nilotinib Nilotinib The metabolism of Tocilizumab can be increased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Bexarotene can be increased when combined with Tocilizumab.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Budesonide is combined with Tocilizumab.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Tocilizumab.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Decitabine is combined with Tocilizumab.
Etravirine Etravirine The metabolism of Etravirine can be increased when combined with Tocilizumab.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Tocilizumab.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tocilizumab.
Cevimeline Cevimeline The metabolism of Cevimeline can be increased when combined with Tocilizumab.
Nebivolol Nebivolol The metabolism of Nebivolol can be increased when combined with Tocilizumab.
Tretinoin Tretinoin The metabolism of Tretinoin can be increased when combined with Tocilizumab.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be increased when combined with Tocilizumab.
Flecainide Flecainide The metabolism of Flecainide can be increased when combined with Tocilizumab.
Certolizumab Injection Certolizumab Injection Tocilizumab may increase the immunosuppressive activities of Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Tocilizumab can be increased when combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be increased when combined with Tocilizumab.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Estramustine is combined with Tocilizumab.
Praziquantel Praziquantel The metabolism of Praziquantel can be increased when combined with Tocilizumab.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Tocilizumab.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Tocilizumab.
Midazolam Midazolam The metabolism of Midazolam can be increased when combined with Tocilizumab.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Tocilizumab.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be increased when combined with Tocilizumab.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Tocilizumab.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Tocilizumab.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be increased when combined with Tocilizumab.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be increased when combined with Tocilizumab.
Betaxolol Betaxolol The metabolism of Betaxolol can be increased when combined with Tocilizumab.
Iloperidone Iloperidone The metabolism of Iloperidone can be increased when combined with Tocilizumab.
Prasugrel Prasugrel The metabolism of Prasugrel can be increased when combined with Tocilizumab.
Lacosamide Lacosamide The metabolism of Lacosamide can be increased when combined with Tocilizumab.
Everolimus Everolimus The metabolism of Everolimus can be increased when combined with Tocilizumab.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be increased when combined with Tocilizumab.
Dronedarone Dronedarone The metabolism of Dronedarone can be increased when combined with Tocilizumab.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be increased when combined with Tocilizumab.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be increased when combined with Tocilizumab.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be increased when combined with Tocilizumab.
Tapentadol Tapentadol The metabolism of Tapentadol can be increased when combined with Tocilizumab.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Topotecan is combined with Tocilizumab.
Ofatumumab Injection (Chronic Lymphocytic Leukemia) Ofatumumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ofatumumab.
Golimumab Injection Golimumab Injection Tocilizumab may increase the immunosuppressive activities of Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be increased when combined with Tocilizumab.
Asenapine Asenapine The metabolism of Asenapine can be increased when combined with Tocilizumab.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be increased when combined with Tocilizumab.
Albendazole Albendazole The metabolism of Albendazole can be increased when combined with Tocilizumab.
Ulipristal Ulipristal The metabolism of Ulipristal can be increased when combined with Tocilizumab.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be increased when combined with Tocilizumab.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be increased when combined with Tocilizumab.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Tocilizumab.
Fingolimod Fingolimod Tocilizumab may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be increased when combined with Tocilizumab.
Ustekinumab Injection Ustekinumab Injection The risk or severity of adverse effects can be increased when Ustekinumab is combined with Tocilizumab.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Tocilizumab.
Vilazodone Vilazodone The metabolism of Vilazodone can be increased when combined with Tocilizumab.
Ipilimumab Injection Ipilimumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Tocilizumab.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tocilizumab.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Tocilizumab.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Tocilizumab.
Roflumilast Roflumilast Tocilizumab may increase the immunosuppressive activities of Roflumilast.
Linagliptin Linagliptin The metabolism of Linagliptin can be increased when combined with Tocilizumab.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Tocilizumab.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Tocilizumab.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be increased when combined with Tocilizumab.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Tocilizumab.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Tocilizumab.
Clobazam Clobazam The metabolism of Clobazam can be increased when combined with Tocilizumab.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Tocilizumab.
Vismodegib Vismodegib The metabolism of Vismodegib can be increased when combined with Tocilizumab.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Tocilizumab.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Tocilizumab.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Tocilizumab.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Tocilizumab.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Tocilizumab.
Cabergoline Cabergoline The metabolism of Cabergoline can be increased when combined with Tocilizumab.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be increased when combined with Tocilizumab.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Eculizumab is combined with Tocilizumab.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Carfilzomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Tocilizumab.
Mirabegron Mirabegron The metabolism of Mirabegron can be increased when combined with Tocilizumab.
Regorafenib Regorafenib The metabolism of Regorafenib can be increased when combined with Tocilizumab.
Bosutinib Bosutinib The metabolism of Bosutinib can be increased when combined with Tocilizumab.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Corticotropin is combined with Tocilizumab.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Tocilizumab is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be increased when combined with Tocilizumab.
Tofacitinib Tofacitinib The risk or severity of adverse effects can be increased when Tocilizumab is combined with Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be increased when combined with Tocilizumab.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Tocilizumab is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be increased when combined with Tocilizumab.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Tocilizumab.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be increased when combined with Tocilizumab.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Tocilizumab.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Tocilizumab.
Ospemifene Ospemifene The metabolism of Ospemifene can be increased when combined with Tocilizumab.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Tocilizumab.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Tocilizumab.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Tocilizumab.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be increased when combined with Tocilizumab.
Lomitapide Lomitapide The metabolism of Lomitapide can be increased when combined with Tocilizumab.
Ketorolac Injection Ketorolac Injection The metabolism of Ketorolac can be increased when combined with Tocilizumab.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Obinutuzumab.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be increased when combined with Tocilizumab.
Apremilast Apremilast The therapeutic efficacy of Apremilast can be decreased when used in combination with Tocilizumab.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Ramucirumab is combined with Tocilizumab.
Ceritinib Ceritinib The metabolism of Ceritinib can be increased when combined with Tocilizumab.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Belinostat is combined with Tocilizumab.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Tocilizumab.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Tocilizumab.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be increased when combined with Tocilizumab.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be increased when combined with Tocilizumab.
Suvorexant Suvorexant The metabolism of Suvorexant can be increased when combined with Tocilizumab.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Pembrolizumab.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be increased when combined with Tocilizumab.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Blinatumomab.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be increased when combined with Tocilizumab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be increased when combined with Tocilizumab.
Riociguat Riociguat The metabolism of Riociguat can be increased when combined with Tocilizumab.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be increased when combined with Tocilizumab.
Nintedanib Nintedanib The metabolism of Nintedanib can be increased when combined with Tocilizumab.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be increased when combined with Tocilizumab.
Palbociclib Palbociclib The metabolism of Palbociclib can be increased when combined with Tocilizumab.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Tocilizumab.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The metabolism of Haloperidol can be increased when combined with Tocilizumab.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Tocilizumab.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Alirocumab.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Tocilizumab.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Evolocumab.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be increased when combined with Tocilizumab.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be increased when combined with Tocilizumab.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be increased when combined with Tocilizumab.
Cariprazine Cariprazine The metabolism of Cariprazine can be increased when combined with Tocilizumab.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Tocilizumab.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Tocilizumab.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Elotuzumab.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Daratumumab.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Tocilizumab.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Tocilizumab.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Tocilizumab.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Necitumumab.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Tocilizumab.
Dexamethasone Injection Dexamethasone Injection The metabolism of Tocilizumab can be increased when combined with Dexamethasone.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Reslizumab.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be increased when combined with Tocilizumab.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Tocilizumab.
Cobicistat Cobicistat The metabolism of Cobicistat can be increased when combined with Tocilizumab.
Selexipag Selexipag The metabolism of Selexipag can be increased when combined with Tocilizumab.
Atezolizumab Injection Atezolizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Atezolizumab.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be increased when combined with Tocilizumab.
Olaratumab Injection Olaratumab Injection The risk or severity of adverse effects can be increased when Olaratumab is combined with Tocilizumab.
Rucaparib Rucaparib The metabolism of Rucaparib can be increased when combined with Tocilizumab.
Bezlotoxumab Injection Bezlotoxumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bezlotoxumab.
Avelumab Injection Avelumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Avelumab.
Ribociclib Ribociclib The metabolism of Ribociclib can be increased when combined with Tocilizumab.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Brigatinib can be increased when combined with Tocilizumab.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be increased when combined with Tocilizumab.
Dupilumab Injection Dupilumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Dupilumab.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Tocilizumab.
Valbenazine Valbenazine The metabolism of Valbenazine can be increased when combined with Tocilizumab.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Tocilizumab is combined with Deflazacort.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Tocilizumab.
Durvalumab Injection Durvalumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Durvalumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Midostaurin can be increased when combined with Tocilizumab.
Neratinib Neratinib The metabolism of Neratinib can be increased when combined with Tocilizumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be increased when combined with Tocilizumab.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Tocilizumab.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Tocilizumab.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Tocilizumab.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Tocilizumab.
Benralizumab Injection Benralizumab Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Benralizumab.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Tocilizumab.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tocilizumab.
Letermovir Letermovir The metabolism of Letermovir can be increased when combined with Tocilizumab.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be increased when combined with Tocilizumab.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be increased when combined with Tocilizumab.
Apalutamide Apalutamide The metabolism of Apalutamide can be increased when combined with Tocilizumab.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ibalizumab.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Tocilizumab.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Erenumab.
Baricitinib Baricitinib The metabolism of Baricitinib can be increased when combined with Tocilizumab.
Burosumab-twza Injection Burosumab-twza Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Burosumab.
Lofexidine Lofexidine The metabolism of Lofexidine can be increased when combined with Tocilizumab.
Eliglustat Eliglustat The metabolism of Eliglustat can be increased when combined with Tocilizumab.
Encorafenib Encorafenib The metabolism of Encorafenib can be increased when combined with Tocilizumab.
Binimetinib Binimetinib The metabolism of Binimetinib can be increased when combined with Tocilizumab.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Tocilizumab.
Elagolix Elagolix The metabolism of Elagolix can be increased when combined with Tocilizumab.
Doravirine Doravirine The metabolism of Doravirine can be increased when combined with Tocilizumab.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be increased when combined with Tocilizumab.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be increased when combined with Tocilizumab.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Cemiplimab.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be increased when combined with Tocilizumab.
Duvelisib Duvelisib The metabolism of Duvelisib can be increased when combined with Tocilizumab.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Mogamulizumab.
Stiripentol Stiripentol The metabolism of Stiripentol can be increased when combined with Tocilizumab.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be increased when combined with Tocilizumab.
Glasdegib Glasdegib The metabolism of Glasdegib can be increased when combined with Tocilizumab.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be increased when combined with Tocilizumab.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Tocilizumab.
Prucalopride Prucalopride The metabolism of Prucalopride can be increased when combined with Tocilizumab.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Emapalumab.
Romosozumab-aqqg Injection Romosozumab-aqqg Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Romosozumab.
Siponimod Siponimod The metabolism of Siponimod can be increased when combined with Tocilizumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be increased when combined with Tocilizumab.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of adverse effects can be increased when Caplacizumab is combined with Tocilizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be increased when combined with Tocilizumab.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be increased when combined with Tocilizumab.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be increased when combined with Tocilizumab.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Tocilizumab.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Polatuzumab vedotin.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be increased when combined with Tocilizumab.
Entrectinib Entrectinib The metabolism of Entrectinib can be increased when combined with Tocilizumab.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be increased when combined with Tocilizumab.
Istradefylline Istradefylline The metabolism of Istradefylline can be increased when combined with Tocilizumab.
Pitolisant Pitolisant The metabolism of Pitolisant can be increased when combined with Tocilizumab.
Fedratinib Fedratinib The metabolism of Fedratinib can be increased when combined with Tocilizumab.
Lefamulin Lefamulin The metabolism of Lefamulin can be increased when combined with Tocilizumab.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Tocilizumab.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be increased when combined with Tocilizumab.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brolucizumab.
Fam-trastuzumab deruxtecan-nxki Injection Fam-trastuzumab deruxtecan-nxki Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Trastuzumab deruxtecan.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be increased when combined with Tocilizumab.
Voxelotor Voxelotor The metabolism of Voxelotor can be increased when combined with Tocilizumab.
Avapritinib Avapritinib The metabolism of Avapritinib can be increased when combined with Tocilizumab.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Tocilizumab.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be decreased when it is combined with Tocilizumab.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be increased when combined with Tocilizumab.
Cenobamate Cenobamate The metabolism of Cenobamate can be increased when combined with Tocilizumab.
Isatuximab-irfc Injection Isatuximab-irfc Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Isatuximab.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Teprotumumab.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be increased when combined with Tocilizumab.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Tocilizumab.
Tucatinib Tucatinib The metabolism of Tucatinib can be increased when combined with Tocilizumab.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Sacituzumab govitecan.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Tocilizumab.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Tocilizumab.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Tocilizumab.
Luspatercept-aamt Injection Luspatercept-aamt Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Luspatercept.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Belantamab mafodotin.
Tafasitamab-cxix Injection Tafasitamab-cxix Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Tafasitamab.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Margetuximab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be increased when combined with Tocilizumab.
Evinacumab-dgnb Injection Evinacumab-dgnb Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Evinacumab.
Aducanumab-avwa Injection Aducanumab-avwa Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Aducanumab.
Anifrolumab-fnia Injection Anifrolumab-fnia Injection The risk or severity of adverse effects can be increased when Tocilizumab is combined with Anifrolumab.
Theophylline Theophylline The metabolism of Theophylline can be increased when combined with Tocilizumab.
Indomethacin Indomethacin The metabolism of Indomethacin can be increased when combined with Tocilizumab.
Mefenamic Acid Mefenamic Acid The metabolism of Mefenamic acid can be increased when combined with Tocilizumab.
Naproxen Naproxen The metabolism of Naproxen can be increased when combined with Tocilizumab.
Trazodone Trazodone The metabolism of Trazodone can be increased when combined with Tocilizumab.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Tocilizumab.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Tocilizumab.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be increased when combined with Tocilizumab.
Methotrexate Injection Methotrexate Injection The metabolism of Tocilizumab can be increased when combined with Methotrexate.
Primidone Primidone The metabolism of Primidone can be increased when combined with Tocilizumab.
Methsuximide Methsuximide The metabolism of Methsuximide can be increased when combined with Tocilizumab.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be increased when combined with Tocilizumab.
Diazepam Diazepam The metabolism of Diazepam can be increased when combined with Tocilizumab.
Flurazepam Flurazepam The metabolism of Flurazepam can be increased when combined with Tocilizumab.
Lorazepam Lorazepam The metabolism of Lorazepam can be increased when combined with Tocilizumab.
Carmustine Carmustine The metabolism of Carmustine can be increased when combined with Tocilizumab.
Codeine Codeine The metabolism of Codeine can be increased when combined with Tocilizumab.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Tocilizumab.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Tocilizumab.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be increased when combined with Tocilizumab.
Thioridazine Thioridazine The metabolism of Thioridazine can be increased when combined with Tocilizumab.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be increased when combined with Tocilizumab.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Tocilizumab.
Dapsone Dapsone The metabolism of Dapsone can be increased when combined with Tocilizumab.
Sulfadiazine Sulfadiazine The metabolism of Sulfadiazine can be increased when combined with Tocilizumab.
Oxycodone Oxycodone The metabolism of Oxycodone can be increased when combined with Tocilizumab.
Methadone Methadone The metabolism of Methadone can be increased when combined with Tocilizumab.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be increased when combined with Tocilizumab.
Benztropine Benztropine The metabolism of Benzatropine can be increased when combined with Tocilizumab.
Maprotiline Maprotiline The metabolism of Maprotiline can be increased when combined with Tocilizumab.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be increased when combined with Tocilizumab.
Perphenazine Perphenazine The metabolism of Perphenazine can be increased when combined with Tocilizumab.
Azathioprine Azathioprine The metabolism of Azathioprine can be increased when combined with Tocilizumab.
Phentermine Phentermine The metabolism of Phentermine can be increased when combined with Tocilizumab.
Amoxapine Amoxapine The metabolism of Amoxapine can be increased when combined with Tocilizumab.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tocilizumab.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Tocilizumab.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Tocilizumab.
Doxorubicin Doxorubicin The metabolism of Tocilizumab can be increased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Tocilizumab.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Tocilizumab.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Tocilizumab.
Carbamazepine Carbamazepine The metabolism of Tocilizumab can be increased when combined with Carbamazepine.
Clonidine Clonidine The metabolism of Clonidine can be increased when combined with Tocilizumab.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Tocilizumab.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Tocilizumab.
Loperamide Loperamide The metabolism of Loperamide can be increased when combined with Tocilizumab.
Promethazine Promethazine The metabolism of Promethazine can be increased when combined with Tocilizumab.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tocilizumab.
Chloroquine Chloroquine The metabolism of Chloroquine can be increased when combined with Tocilizumab.
Quinine Quinine The metabolism of Quinine can be increased when combined with Tocilizumab.
Ethosuximide Ethosuximide The metabolism of Ethosuximide can be increased when combined with Tocilizumab.
Triamterene Triamterene The metabolism of Triamterene can be increased when combined with Tocilizumab.
Isosorbide Isosorbide The metabolism of Isosorbide can be increased when combined with Tocilizumab.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Tocilizumab.
Desipramine Desipramine The metabolism of Desipramine can be increased when combined with Tocilizumab.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be increased when combined with Tocilizumab.
Imipramine Imipramine The metabolism of Imipramine can be increased when combined with Tocilizumab.
Quinidine Quinidine The metabolism of Quinidine can be increased when combined with Tocilizumab.
Procainamide Procainamide The metabolism of Procainamide can be increased when combined with Tocilizumab.
Disopyramide Disopyramide The metabolism of Disopyramide can be increased when combined with Tocilizumab.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be increased when combined with Tocilizumab.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Tocilizumab.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Tocilizumab.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Tocilizumab.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Tocilizumab.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be increased when combined with Tocilizumab.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be increased when combined with Tocilizumab.
Tolazamide Tolazamide The metabolism of Tolazamide can be increased when combined with Tocilizumab.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be increased when combined with Tocilizumab.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be increased when combined with Tocilizumab.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be increased when combined with Tocilizumab.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be increased when combined with Tocilizumab.
Meclizine Meclizine The metabolism of Meclizine can be increased when combined with Tocilizumab.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be increased when combined with Tocilizumab.
Carisoprodol Carisoprodol The metabolism of Carisoprodol can be increased when combined with Tocilizumab.
Disulfiram Disulfiram The metabolism of Disulfiram can be increased when combined with Tocilizumab.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be increased when combined with Tocilizumab.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be increased when combined with Tocilizumab.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Tocilizumab.
Nadolol Nadolol The metabolism of Nadolol can be increased when combined with Tocilizumab.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be increased when combined with Tocilizumab.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Colchicine is combined with Tocilizumab.
Cephalexin Cephalexin The metabolism of Cephalexin can be increased when combined with Tocilizumab.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be increased when combined with Tocilizumab.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Tocilizumab.
Thiotepa Injection Thiotepa Injection The metabolism of Tocilizumab can be increased when combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be increased when combined with Tocilizumab.
Vinblastine Vinblastine The metabolism of Tocilizumab can be increased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be increased when combined with Tocilizumab.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be increased when combined with Tocilizumab.
Thiothixene Thiothixene The metabolism of Thiothixene can be increased when combined with Tocilizumab.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be increased when combined with Tocilizumab.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Tocilizumab.
Alprazolam Alprazolam The metabolism of Alprazolam can be increased when combined with Tocilizumab.
Triazolam Triazolam The metabolism of Triazolam can be increased when combined with Tocilizumab.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be increased when combined with Tocilizumab.
Diltiazem Diltiazem The metabolism of Diltiazem can be increased when combined with Tocilizumab.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Tocilizumab.
Timolol Timolol The metabolism of Timolol can be increased when combined with Tocilizumab.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Tocilizumab.
Atenolol Atenolol The metabolism of Atenolol can be increased when combined with Tocilizumab.
Pindolol Pindolol The metabolism of Pindolol can be increased when combined with Tocilizumab.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Tocilizumab.
Piroxicam Piroxicam The metabolism of Piroxicam can be increased when combined with Tocilizumab.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Tocilizumab.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Tocilizumab.
Glyburide Glyburide The metabolism of Glyburide can be increased when combined with Tocilizumab.
Glipizide Glipizide The metabolism of Glipizide can be increased when combined with Tocilizumab.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be increased when combined with Tocilizumab.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be increased when combined with Tocilizumab.
Labetalol Labetalol The metabolism of Labetalol can be increased when combined with Tocilizumab.
Guanabenz Guanabenz The metabolism of Guanabenz can be increased when combined with Tocilizumab.
Pimozide Pimozide The metabolism of Pimozide can be increased when combined with Tocilizumab.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be increased when combined with Tocilizumab.
Amiodarone Amiodarone The metabolism of Amiodarone can be increased when combined with Tocilizumab.
Buspirone Buspirone The metabolism of Buspirone can be increased when combined with Tocilizumab.
Lovastatin Lovastatin The metabolism of Lovastatin can be increased when combined with Tocilizumab.
Diclofenac Diclofenac The metabolism of Diclofenac can be increased when combined with Tocilizumab.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be increased when combined with Tocilizumab.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Tocilizumab.
Clozapine Clozapine The metabolism of Clozapine can be increased when combined with Tocilizumab.
Idarubicin Idarubicin The metabolism of Idarubicin can be increased when combined with Tocilizumab.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Tocilizumab.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Tocilizumab.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be increased when combined with Tocilizumab.
Etodolac Etodolac The metabolism of Etodolac can be increased when combined with Tocilizumab.
Felodipine Felodipine The metabolism of Felodipine can be increased when combined with Tocilizumab.
Nabumetone Nabumetone The metabolism of Nabumetone can be increased when combined with Tocilizumab.
Simvastatin Simvastatin The metabolism of Simvastatin can be increased when combined with Tocilizumab.
Amlodipine Amlodipine The metabolism of Amlodipine can be increased when combined with Tocilizumab.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be increased when combined with Tocilizumab.
Sotalol Sotalol The metabolism of Sotalol can be increased when combined with Tocilizumab.
Zolpidem Zolpidem The metabolism of Zolpidem can be increased when combined with Tocilizumab.
Doxazosin Doxazosin The metabolism of Doxazosin can be increased when combined with Tocilizumab.
Omeprazole Omeprazole The metabolism of Omeprazole can be increased when combined with Tocilizumab.
Cisapride Cisapride The metabolism of Cisapride can be increased when combined with Tocilizumab.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be increased when combined with Tocilizumab.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be increased when combined with Tocilizumab.
Famciclovir Famciclovir The metabolism of Famciclovir can be increased when combined with Tocilizumab.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be increased when combined with Tocilizumab.
Nefazodone Nefazodone The metabolism of Nefazodone can be increased when combined with Tocilizumab.
Losartan Losartan The metabolism of Losartan can be increased when combined with Tocilizumab.
Tramadol Tramadol The metabolism of Tramadol can be increased when combined with Tocilizumab.
Vinorelbine Injection Vinorelbine Injection The metabolism of Tocilizumab can be increased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Tocilizumab.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be increased when combined with Tocilizumab.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Tocilizumab.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Tocilizumab.
Nicardipine Nicardipine The metabolism of Nicardipine can be increased when combined with Tocilizumab.
Bupropion Bupropion The metabolism of Bupropion can be increased when combined with Tocilizumab.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be increased when combined with Tocilizumab.
Saquinavir Saquinavir The metabolism of Saquinavir can be increased when combined with Tocilizumab.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be increased when combined with Tocilizumab.
Riluzole Riluzole The metabolism of Riluzole can be increased when combined with Tocilizumab.
Glimepiride Glimepiride The metabolism of Glimepiride can be increased when combined with Tocilizumab.
Anastrozole Anastrozole The metabolism of Anastrozole can be increased when combined with Tocilizumab.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tocilizumab.
Indinavir Indinavir The metabolism of Indinavir can be increased when combined with Tocilizumab.
Ritonavir Ritonavir The metabolism of Ritonavir can be increased when combined with Tocilizumab.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be increased when combined with Tocilizumab.
Clomipramine Clomipramine The metabolism of Clomipramine can be increased when combined with Tocilizumab.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be increased when combined with Tocilizumab.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be increased when combined with Tocilizumab.
Zileuton Zileuton The metabolism of Zileuton can be increased when combined with Tocilizumab.
Valsartan Valsartan The metabolism of Valsartan can be increased when combined with Tocilizumab.
Donepezil Donepezil The metabolism of Donepezil can be increased when combined with Tocilizumab.
Azithromycin Azithromycin The metabolism of Azithromycin can be increased when combined with Tocilizumab.
Carvedilol Carvedilol The metabolism of Carvedilol can be increased when combined with Tocilizumab.
Flutamide Flutamide The metabolism of Flutamide can be increased when combined with Tocilizumab.
Selegiline Selegiline The metabolism of Selegiline can be increased when combined with Tocilizumab.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be increased when combined with Tocilizumab.
Sertraline Sertraline The metabolism of Sertraline can be increased when combined with Tocilizumab.
Propafenone Propafenone The metabolism of Propafenone can be increased when combined with Tocilizumab.
Letrozole Letrozole The metabolism of Letrozole can be increased when combined with Tocilizumab.
Irbesartan Irbesartan The metabolism of Irbesartan can be increased when combined with Tocilizumab.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be increased when combined with Tocilizumab.
Ropinirole Ropinirole The metabolism of Ropinirole can be increased when combined with Tocilizumab.
Finasteride Finasteride The metabolism of Finasteride can be increased when combined with Tocilizumab.
Quetiapine Quetiapine The metabolism of Quetiapine can be increased when combined with Tocilizumab.
Paroxetine Paroxetine The metabolism of Paroxetine can be increased when combined with Tocilizumab.
Palivizumab Injection Palivizumab Injection The risk or severity of adverse effects can be increased when Palivizumab is combined with Tocilizumab.
Citalopram Citalopram The metabolism of Citalopram can be increased when combined with Tocilizumab.
Capecitabine Capecitabine The metabolism of Tocilizumab can be increased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Efavirenz can be increased when combined with Tocilizumab.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Tocilizumab.
Pioglitazone Pioglitazone The metabolism of Pioglitazone can be increased when combined with Tocilizumab.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Tocilizumab.
Celecoxib Celecoxib The metabolism of Celecoxib can be increased when combined with Tocilizumab.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be increased when combined with Tocilizumab.
Tolterodine Tolterodine The metabolism of Tolterodine can be increased when combined with Tocilizumab.
Thalidomide Thalidomide The metabolism of Thalidomide can be increased when combined with Tocilizumab.
Nateglinide Nateglinide The metabolism of Nateglinide can be increased when combined with Tocilizumab.
Galantamine Galantamine The metabolism of Galantamine can be increased when combined with Tocilizumab.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be increased when combined with Tocilizumab.
Terbinafine Terbinafine The metabolism of Terbinafine can be increased when combined with Tocilizumab.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists